EN DE
Watch Phenixfin Corporation for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Phenixfin Corporation (PFX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Phenixfin Corporation stock $27.97, price $42.03, that is 33.4% below the price, quality 46 out of 100. Rating: overvalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US

PC Phenixfin Corporation logo Some data Nov 6, 2026

Phenixfin Corporation

PFX · US
Expensive, weak quality

Our calculation puts a fair price 33% below what the stock costs today.

Solidly profitable · 18.6% net margin (TTM)
Quality 46/100
Mixed Growth (revenue 5y +2.3 %/yr in USD)
Moderate moat 51/100 · thin data
Insiders bought $2.1M (6M)
Some data
Profit last quarter 33% below a year ago.
Fair value $27.97 · Overvalued
Negative free cash flow
Trails peers (3/13)
Watch Phenixfin Corporation for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$54.41 $13.25 Fair Value $27.97 Jul 2020 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $13.25 – $54.41 · fair‑value band $20.98 – $34.97 · the $42.03 price screens above the $27.97 fair value. As of Nov 6, 2026.

Follow Phenixfin in your weekly email

Every Wednesday you see whether Phenixfin is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PhenixFIN Corporation is a business development company. The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies.

Show moreShow less

It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport.

The firm seeks to invest in companies located in North America. The firm targets private debt transactions in companies with enterprise values or asset values between $25 million and $250 million. The firm seeks to invest in companies with debt investment values between $10 million and $50 million.

It exits its investments between three years and seven years; it holds most of its investments to maturity or repayment, but may realize or sell some investments earlier. The firm may take a board seat on its investee companies and can also offer managerial assistance to certain portfolio companies.

It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, subordinate notes, unitranche loans, and seeks warrants or other equity participation.

The firm may co-invest in privately negotiated transactions under certain conditions. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York.

Stock analysis

Phenixfin Corporation (PFX) currently trades at $42.03, while our model-based Fair Value estimate is $27.97, 33% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of $55.78 per share, and 3 of the 7 models we run sit above the $42.03 price.

Bear case: the Dividend Discount group reads lowest at $17.70, and 4 of the 7 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $20.98 (bear) to $34.97 (bull), the price of $42.03 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Financial Services sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Phenixfin Corporation reported revenue of $24.1M in FY2025 versus $8.2M in FY2021, a compound +30.7%/yr. Reported net income was $4.2M in FY2025, compounding +34.3%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap $81.2M Micro · P/E ratio 18.0 · P/S ratio 3.23 · EPS (TTM) $2.33 · Dividend yield 3.4% · Net margin 18.6% · Return on equity 3.0% · Return on assets (EBIT) 466% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −16% fair-value upside, at −33%, PFX screens richer than that median.

Fair Value models

Bear $20.98 Fair Value $27.97 Bull $34.97
Price $42.03 · Downside -33.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($2.33 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income $52.77 $53.51 $56.10 76
Gordon GGM $11.42 $19.11 $27.24 68
DDM Multi-Stage $11.42 $16.28 $20.79 67
All 7 models by family
Earnings-Based
Graham-Dodd $14.63 $37.03 $48.12 65
Dividend Discount
Gordon GGM $11.42 $19.11 $27.24 68
DDM Multi-Stage $11.42 $16.28 $20.79 67
Multiples
P/E Multiple $20.98 $27.97 $34.97 63
P/B Multiple $37.52 $50.03 $62.54 55
Asset-Based
NCAV (Graham) $41.62 $55.78 $83.25 51
Economic Profit
Residual Income $52.77 $53.51 $56.10 76

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 26
How much profit the company makes from its sales and capital
Quality Growth 6
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 47
Debt, balance sheet and risk of trouble
Investment 62
Does it invest with discipline instead of growing at any price?
Low Volatility 69
How calm the share price moves, does not count
Price momentum 36
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 21
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director bought shares worth $2.1M, on Jun 3, 2026.

  • BuyDavid A LorberCHAIRMAN AND CEO, Director, 10% owner4× since Dec 15, 2025: 53,572 shares, avg. $41.05$2.2MJun 3, 2026
  • BuyHoward AmsterDirector, 10% owner11,500 shares at $42.56$489,440Mar 3, 2026
  • BuyEllida McMillanCHIEF FINANCIAL OFFICER2× since Dec 17, 2025: 193 shares, avg. $45.06$8,698Dec 23, 2025

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 21/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−31.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+56.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
Start year 2020 (pandemic). Over 10 years: +1.4% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.9%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+37.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+34.0%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.34.0% vs −21.1%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−306% → 16%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 7.0%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

PFX screens overvalued: fair value 33% below the price. Compare with Blackstone Inc →

Compare Phenixfin Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 587 stocks

Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Bottom 25%
Fair Value upside −33.4% · Bottom 25%
Profitability
Return on equity (12 months) 3.0% · Below median
Return on assets 1.3% · Below median
Net margin (12 months) 18.6% · Below median
Operating margin (12 months) 68.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 4.8% · Below median
Dividend yield (12 months) 3.4% · Below median

Valuation Multiplesvs Asset Management median · lower = cheaper

P/E (12 months) 18.0× · Pricier than median
P/B 0.51× · Cheapest 25%
P/S (12 months) 3.23× · Cheaper than median
EV/EBITDA 18.7× · Priciest 25%
PEG 8.40× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 60
FUTURE (revenue growth)24 · sector 38
PAST (return on equity)12 · sector 29
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)67 · sector 80

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Exor N.V EXO €73.35 €139.37 +90% vs PFX
Raymond James Financial, Inc RJF $162.81 $281.42 +73% vs PFX
Apollo Global Management, Inc APO $116.75 $197.52 +69% vs PFX
Ameriprise Financial, Inc AMP $501.49 $609.56 +22% vs PFX
State Street Corporation STT $165.56 $139.37 −16% vs PFX
Ares Management Corporation ARES $133.98 $99.35 −26% vs PFX
Northern Trust Corporation NTRS $172.76 $123.42 −29% vs PFX
Brookfield Asset Management Ltd BAM $52.95 $31.26 −41% vs PFX
Blackstone Inc BX $119.50 $52.29 −56% vs PFX
KKR & Co KKR $96.48 $27.32 −72% vs PFX

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Phenixfin Corporation: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Phenixfin Corporation Fair Value". https://www.fairvalue-calculator.com/stock/PFX

Frequently asked questions

Is Phenixfin Corporation (PFX) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $27.97 versus a price of $42.03, about 33% lower (overvalued).
What is the fair value of PFX?
Our model-based fair value for Phenixfin Corporation is $27.97 (as of Nov 6, 2026), built from audited fundamentals. The current price: $42.03.
What is the quality score of PFX?
Phenixfin Corporation has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Phenixfin Corporation (PFX)?
Our model-based price target is the fair value of $27.97 (as of Nov 6, 2026) from 7 valuation models. Cautious scenario $20.98, optimistic scenario $34.97. It is a calculation from audited fundamentals, not an analyst target.
What is the Phenixfin Corporation stock forecast for 2026?
Our models put fair value at $27.97, about 33% lower versus a price of $42.03 (overvalued). Cautious scenario $20.98, optimistic scenario $34.97. The calculation is refreshed regularly with new filings.
What is the revenue of Phenixfin Corporation (PFX)?
Phenixfin Corporation reported trailing-twelve-month revenue of about $25.2M (latest available figure, as of Nov 6, 2026).
Does Phenixfin Corporation pay a dividend?
Phenixfin Corporation currently shows a dividend yield of 3.35% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Phenixfin Corporation (PFX)?
Phenixfin Corporation has a dividend yield of 3.4%.
What is the intrinsic value of Phenixfin Corporation (PFX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Phenixfin Corporation it is $27.97 per share (as of Nov 6, 2026), against a price of $42.03. It is the blended result of 7 valuation models in 5 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit).
Is Phenixfin Corporation stock overvalued or undervalued in 2026?
As of Nov 6, 2026, PFX trades above its calculated fair value: price $42.03, fair value $27.97, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PFX?
No. The price is what the market pays today ($42.03); the fair value is what the company's own numbers justify ($27.97). For Phenixfin Corporation the two are $14.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is Phenixfin Corporation worth?
The market values Phenixfin Corporation at about $81.2M (market capitalisation, as of Nov 6, 2026). Per share that is $42.03; our models calculate a fair value of $27.97 per share.
What do the bullish and bearish scenarios say about PFX?
Our models span a range for Phenixfin Corporation: cautious scenario $20.98, base $27.97, optimistic $34.97 per share (as of Nov 6, 2026, price $42.03). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PFX?
Phenixfin Corporation trades at a price-to-earnings ratio of 18.0 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $27.97 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 16.5 (reported for FY2025: 20.2). Other multiples: PEG 8.4, P/B 0.5, P/S 3.2, EV/EBITDA 18.7.
What is the PEG ratio of PFX?
The PEG ratio of Phenixfin Corporation is 8.40 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Phenixfin Corporation (PFX)?
Balance-sheet figures for Phenixfin Corporation (as of Nov 6, 2026): return on equity 3.0%. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is PFX from its 52-week high?
Phenixfin Corporation trades at $42.03, about 23% below its 52-week high of $54.41 and 10% above the low of $38.23 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $27.97 is for.
Which stocks are comparable to Phenixfin Corporation?
From the same area (Financial Services) we also value Blackstone Inc, Brookfield Asset Management Ltd, KKR & Co, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Phenixfin Corporation stock attractive at the current price?
The data as of Nov 6, 2026: price $42.03, calculated fair value $27.97 (−33%), Quality Score 46/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PFX calculated?
We run Phenixfin Corporation through 7 models from 5 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of $27.97 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Phenixfin Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Phenixfin Corporation (PFX)?
The closing price on Nov 6, 2026 was $42.03. Our model-based fair value is $27.97, about 33% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Phenixfin Corporation right now?
The price sits above even our optimistic bull case ($34.97). The favourable scenario is already priced in. Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of Phenixfin Corporation

How large is the market capitalisation of Phenixfin Corporation (PFX)?
The market capitalisation of Phenixfin Corporation is $81.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Phenixfin Corporation (PFX)?
The price-to-sales ratio of Phenixfin Corporation is 3.23 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Phenixfin Corporation (PFX)?
Earnings per share at Phenixfin Corporation are $2.33 (price ÷ EPS = P/E 18.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Phenixfin Corporation (PFX)?
The dividend yield of Phenixfin Corporation is 3.4% (payout 60.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Phenixfin Corporation (PFX)?
The net margin of Phenixfin Corporation is 18.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Phenixfin Corporation (PFX)?
The return on equity (ROE) of Phenixfin Corporation is 3.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Phenixfin Corporation (PFX)?
On an EBIT basis the return on assets of Phenixfin Corporation is 466% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Phenixfin Corporation (PFX)?
The operating margin of Phenixfin Corporation is 68.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Phenixfin Corporation (PFX)?
Revenue at Phenixfin Corporation is growing +4.8% versus a year earlier (3y avg +56.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Phenixfin Corporation (PFX)?
Earnings per share at Phenixfin Corporation are growing −32.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Phenixfin Corporation (PFX) generate?
The free cash flow of Phenixfin Corporation is −$168M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Phenixfin Corporation (PFX) carry?
The net debt of Phenixfin Corporation is $141M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Phenixfin Corporation in the live analysis

One click puts Phenixfin Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.